Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 25.24 -0.3 (1.17%)
Previous Close $25.54    52 Week High
Open $25.74    52 Week Low
Day High $25.74    P/E N/A 
Day Low $25.02    EPS
Volume 2,897,087